Scholars Central

Conference abstractPublished 26 Jun 2017

Immunosuppression in tumors: Galectins cover human tumor-infiltrating lymphocytes and block their functions

Authors: Pierre van der Bruggen, Monica Gordon-Alonso, Anne-Elisabeth Petit

UniversitÃ?© Catholique de Louvain, Belgium

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

We describe a new mechanism of dysfunction of human tumor-infiltrating lymphocytes (TILs). TILs failed to secrete cytokines and lytic enzymes upon stimulation, although they were normally activated and able to produce these effector molecules inside the cell. Surprisingly, these effector molecules remained trapped inside the cell. This defect is related to the presence of galectin-3 at the TIL surface and can be relieved by agents that detach galectin-3 from the TIL surface. The normal secretion process is blocked in dysfunctional TILs, due to impaired LFA-1 mobility and actin rearrangement at the secretory synapse. This is the first observation of uncoupling between cytokine production and cytokine secretion in TILs. We also hypothesize that galectins lattices hanged on the tumor microenvironment may capture glycosylated immune factors, blocking their anti-tumor function. The presence of galectin-3 in the tumor microenvironment reduced IFNÃ?³ diffusion and ability to induce the chemokine gradient necessary to attract anti-tumor T-lymphocytes. Galectin-3 captured in vitro glycosylated IFNÃ?³ and reduces IFNÃ?³ diffusion through a collagen matrix. Inhibiting galectins enhanced the capacity of human tumor cells to express CXCL9/10 upon IFNÃ?³ treatment in vitro. In a humanized mouse model, human galectin-3 restricts the intratumor diffusion of IFNÃ?³. Co-injection of IFNÃ?³ and galectin antagonists improved tumor infiltration by autologous CD8+ T cells injected intravenously and delayed tumor growth as compared with tumors injected with IFNÃ?³ alone. Our results contribute to explain why some human tumors can be considered as cold as they are poorly infiltrated by anti-tumor T-lymphocytes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Glycobiology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Glycobiology
  • SubjectImmunology & Microbiology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Pierre van der Bruggen”
  • BylineArticles whose byline prints “Monica Gordon-Alonso”
  • BylineArticles whose byline prints “Anne-Elisabeth Petit”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels